FDA Approved: SODIUM POLYSTYRENE SULFONATE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved an original ANDA for sodium polystyrene sulfonate from Chartwell RX, LLC, establishing a generic product for the treatment of hyperkalemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Sodium polystyrene sulfonate (Sodium polystyrene sulfonate)

Snippet

ORIG AP for SODIUM POLYSTYRENE SULFONATE (SODIUM POLYSTYRENE SULFONATE)